loading
前日終値:
$2.90
開ける:
$2.95
24時間の取引高:
537.14K
Relative Volume:
1.47
時価総額:
$147.26M
収益:
$226.63M
当期純損益:
$15.38M
株価収益率:
-60.00
EPS:
-0.05
ネットキャッシュフロー:
$35.61M
1週間 パフォーマンス:
+23.97%
1か月 パフォーマンス:
+5.63%
6か月 パフォーマンス:
-29.08%
1年 パフォーマンス:
-27.54%
1日の値動き範囲:
Value
$2.8864
$3.1397
1週間の範囲:
Value
$2.32
$3.1397
52週間の値動き範囲:
Value
$2.225
$7.73

Puma Biotechnology Inc Stock (PBYI) Company Profile

Name
名前
Puma Biotechnology Inc
Name
セクター
Healthcare (1195)
Name
電話
(424) 248-6500
Name
住所
10880 WILSHIRE BLVD., LOS ANGELES, CA
Name
職員
185
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
PBYI's Discussions on Twitter

PBYI を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
PBYI 3.00 147.26M 226.63M 15.38M 35.61M -0.05
VRTX 450.97 116.14B 10.63B -479.80M -1.35B 13.33
REGN 738.00 81.10B 13.85B 4.65B 3.32B 35.06
ARGX 605.92 36.23B 1.86B -40.29M -1.28B -4.16
ALNY 244.89 31.59B 2.09B -332.26M 16.06M -4.14
BNTX 113.13 27.12B 3.30B -501.07M 1.03B 11.54

Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2021-09-28 アップグレード Citigroup Neutral → Buy
2020-06-25 再開されました BofA/Merrill Underperform
2019-10-08 ダウングレード Goldman Neutral → Sell
2019-05-10 ダウングレード Cantor Fitzgerald Overweight → Neutral
2019-05-10 ダウングレード Citigroup Buy → Neutral
2019-01-17 開始されました Leerink Partners Mkt Perform
2019-01-03 ダウングレード Guggenheim Buy → Neutral
2018-11-19 アップグレード Goldman Sell → Neutral
2018-11-02 ダウングレード BofA/Merrill Buy → Underperform
2018-11-02 ダウングレード JP Morgan Neutral → Underweight
2018-10-01 開始されました Cantor Fitzgerald Overweight
2018-09-17 開始されました Goldman Sell
2018-05-11 繰り返されました Stifel Buy
2017-11-10 繰り返されました Citigroup Buy
2017-11-10 繰り返されました RBC Capital Mkts Sector Perform
2017-10-02 繰り返されました Stifel Buy
2017-09-11 繰り返されました Credit Suisse Outperform
2017-07-10 再開されました Leerink Partners Outperform
2017-06-06 繰り返されました RBC Capital Mkts Sector Perform
2017-05-25 繰り返されました RBC Capital Mkts Sector Perform
2017-03-02 繰り返されました RBC Capital Mkts Sector Perform
すべてを表示

Puma Biotechnology Inc (PBYI) 最新ニュース

pulisher
12:57 PM

Puma Biotechnology (NASDAQ:PBYI) Downgraded by StockNews.com to Buy - MarketBeat

12:57 PM
pulisher
Nov 22, 2024

PBYI Begins Phase II Study on Alisertib Combo in Breast Cancer - MSN

Nov 22, 2024
pulisher
Nov 21, 2024

Puma commences Phase II trial of alisertib for breast cancer treatment - Clinical Trials Arena

Nov 21, 2024
pulisher
Nov 20, 2024

Puma Biotech Launches Phase 2 Trial for Advanced Breast Cancer Treatment | PBYI Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 17, 2024

245,695 Shares in Puma Biotechnology, Inc. (NASDAQ:PBYI) Bought by Los Angeles Capital Management LLC - MarketBeat

Nov 17, 2024
pulisher
Nov 14, 2024

Puma Biotechnology's (NASDAQ:PBYI) Performance Is Even Better Than Its Earnings Suggest - Simply Wall St

Nov 14, 2024
pulisher
Nov 14, 2024

We Think Puma Biotechnology's (NASDAQ:PBYI) Robust Earnings Are Conservative - Yahoo Finance

Nov 14, 2024
pulisher
Nov 13, 2024

Puma Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024
pulisher
Nov 09, 2024

Puma Biotechnology Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 09, 2024
pulisher
Nov 09, 2024

Puma Biotechnology, Inc. (NASDAQ:PBYI) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024
pulisher
Nov 08, 2024

Earnings call: Puma Biotechnology reports robust Q3 growth - Investing.com

Nov 08, 2024
pulisher
Nov 08, 2024

Earnings call: Puma Biotechnology reports robust Q3 growth By Investing.com - Investing.com UK

Nov 08, 2024
pulisher
Nov 08, 2024

Puma Biotechnology's (PBYI) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

PBYI Beats Q3 Earnings & Revenue Estimates, Revises '24 View, Stock Up - Nasdaq

Nov 08, 2024
pulisher
Nov 07, 2024

Puma Biotechnology Reports Strong Q3 2024 Growth - TipRanks

Nov 07, 2024
pulisher
Nov 07, 2024

Puma Biotechnology Q3 2024 Earnings Preview - MSN

Nov 07, 2024
pulisher
Nov 07, 2024

Puma Biotech (PBYI) Q3 Earnings and Revenues Surpass Estimates - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

Puma Biotechnology Reports Third Quarter 2024 Financial Results - sharewise

Nov 07, 2024
pulisher
Nov 07, 2024

Puma Biotech: Q3 Earnings Snapshot - San Francisco Chronicle

Nov 07, 2024
pulisher
Nov 05, 2024

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - sharewise

Nov 05, 2024
pulisher
Nov 05, 2024

Puma Biotechnology Grants 5,625-Share Inducement Award to New Employee | PBYI | PBYI Stock News - StockTitan

Nov 05, 2024
pulisher
Nov 01, 2024

Puma Biotechnology (NASDAQ:PBYI) Raised to "Strong-Buy" at StockNews.com - MarketBeat

Nov 01, 2024
pulisher
Oct 31, 2024

Puma Biotechnology (PBYI) Set to Announce Quarterly Earnings on Thursday - MarketBeat

Oct 31, 2024
pulisher
Oct 29, 2024

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation - GlobeNewswire

Oct 29, 2024
pulisher
Oct 29, 2024

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Puma Biotechnology, Inc. (NASDAQ - The Bakersfield Californian

Oct 29, 2024
pulisher
Oct 28, 2024

3 US Penny Stocks With Market Caps Under $700M - Simply Wall St

Oct 28, 2024
pulisher
Oct 24, 2024

Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results - BioSpace

Oct 24, 2024
pulisher
Oct 24, 2024

Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results | PBYI Stock News - StockTitan

Oct 24, 2024
pulisher
Oct 23, 2024

Puma Biotechnology (NASDAQ:PBYI) Rating Increased to Strong-Buy at StockNews.com - MarketBeat

Oct 23, 2024
pulisher
Oct 21, 2024

What is Zacks Research's Forecast for PBYI FY2026 Earnings? - MarketBeat

Oct 21, 2024
pulisher
Oct 18, 2024

Equities Analysts Offer Predictions for PBYI Q3 Earnings - MarketBeat

Oct 18, 2024
pulisher
Oct 13, 2024

With A Return On Equity Of 18%, Has Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Management Done Well? - Yahoo Finance

Oct 13, 2024
pulisher
Oct 05, 2024

Puma Biotechnology quickly drops after patents for Tagrisso ruled invalid - MSN

Oct 05, 2024
pulisher
Sep 30, 2024

FY2025 EPS Estimates for Puma Biotechnology, Inc. (NASDAQ:PBYI) Decreased by Zacks Research - MarketBeat

Sep 30, 2024
pulisher
Sep 29, 2024

Frazier Life Sciences Management L.P. Purchases 246,264 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - MarketBeat

Sep 29, 2024
pulisher
Sep 25, 2024

Affinity Asset Advisors LLC Makes New $815,000 Investment in Puma Biotechnology, Inc. (NASDAQ:PBYI) - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

Fred Alger Management LLC Raises Stake in Hamilton Lane Incorporated (NASDAQ:HLNE) - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

Hsbc Holdings PLC Has $4.29 Million Position in Grupo Financiero Galicia S.A. (NASDAQ:GGAL) - MarketBeat

Sep 25, 2024
pulisher
Sep 24, 2024

The growth track for Humacyte Inc (HUMA) has changed recently - SETE News

Sep 24, 2024
pulisher
Sep 24, 2024

Humacyte: Navigating The FDA Uncertainty And ATEV’s Potential (NASDAQ:HUMA) - Seeking Alpha

Sep 24, 2024
pulisher
Sep 24, 2024

Puma VCT 13 Launches £70M Share Offer - TipRanks

Sep 24, 2024
pulisher
Sep 23, 2024

HUTCHMED (NASDAQ:HCM) Shares Gap Down to $17.38 - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

It is Poised to be a Bull Market for Puma Biotechnology Inc (PBYI) - SETE News

Sep 23, 2024
pulisher
Sep 22, 2024

American Century Companies Inc. Sells 186,924 Shares of Foot Locker, Inc. (NYSE:FL) - Defense World

Sep 22, 2024
pulisher
Sep 20, 2024

Bank of America Raises Trupanion (NASDAQ:TRUP) Price Target to $56.00 - MarketBeat

Sep 20, 2024
pulisher
Sep 20, 2024

Achilles Thera shifts focus to new cancer treatment avenues - The Pharma Letter

Sep 20, 2024
pulisher
Sep 19, 2024

Insider Selling: Sebelius Kathleen, Humacyte Inc [HUMA] Director divested 5,182 shares - Knox Daily

Sep 19, 2024
pulisher
Sep 19, 2024

A$AP Rocky’s Lineup of Puma Sneakers Is Quickly Growing Bigger - Yahoo! Voices

Sep 19, 2024
pulisher
Sep 19, 2024

Achilles gains on plans to explore strategic options - XM

Sep 19, 2024
pulisher
Sep 19, 2024

Achilles Therapeutics Shares Are Trading Higher: What You Need To Know - Benzinga

Sep 19, 2024
pulisher
Sep 19, 2024

Puma VCT 13 PLC Executes Share Buyback - TipRanks

Sep 19, 2024

Puma Biotechnology Inc (PBYI) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$71.72
price up icon 1.89%
$19.00
price up icon 3.15%
$41.11
price up icon 7.48%
$372.89
price up icon 1.51%
$190.51
price down icon 2.08%
$113.13
price up icon 4.53%
大文字化:     |  ボリューム (24 時間):